Norwich Adds Business Development Leaders

Norwich has added three business development leaders. Mitchell Winfree has been appointed vice president of business development and Gregory Downs and Bob Peoples have joined the company as directors of business development.
 
Mr. Winfree joins Norwich Clinical Services to develop and lead the regional expansion for the CRO business in North America. Mr. Winfree has a track record for leading successful business development operations for both large, global CROs as well as smaller, therapeutically focused providers. He has nearly 20 years of experience in discovery, preclinical, and clinical research having held positions with PPD, Rho, and Clinsys Clinical Research.

Mr. Downs has more than 15 years of pharmaceutical, clinical testing and development sales experience, with additional expertise in clinical pharmacy and analytical testing. He is responsible for expanding Norwich operations in the northeast U.S. and eastern Canada. Mr. Downs has held leadership positions in business development with Azopharma, Biovail and Aurobindo Pharma.

Mr. Peoples has more than 25 years of experience in pharmaceutical manufacturing, sales and marketing. He will be responsible for growing Norwich business in the southeast U.S. He has directed manufacturing and packaging operations at Burroughs Welcome and DSM Pharmaceuticals and has spent the last 10 years in sales and customer service.
 
“We’re extremely pleased to welcome Mitchell, Greg and Bob to Norwich,” said Terry Novak, president of Norwich Pharmaceuticals. “Their leadership will be instrumental as Norwich further expands our capability to provide customers with one comprehensive solution for all stages of the product lifecycle.”